SE0201939D0 - New combination - Google Patents

New combination

Info

Publication number
SE0201939D0
SE0201939D0 SE0201939A SE0201939A SE0201939D0 SE 0201939 D0 SE0201939 D0 SE 0201939D0 SE 0201939 A SE0201939 A SE 0201939A SE 0201939 A SE0201939 A SE 0201939A SE 0201939 D0 SE0201939 D0 SE 0201939D0
Authority
SE
Sweden
Prior art keywords
new combination
relates
disease
reflux
thrive
Prior art date
Application number
SE0201939A
Other languages
English (en)
Inventor
Anders Lehmann
Michael Wrangstadh
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0201939A priority Critical patent/SE0201939D0/sv
Publication of SE0201939D0 publication Critical patent/SE0201939D0/sv
Priority to ARP030102094A priority patent/AR040202A1/es
Priority to AU2003239025A priority patent/AU2003239025A1/en
Priority to PCT/SE2003/001007 priority patent/WO2004000855A1/en
Priority to TW092116263A priority patent/TW200400826A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/04—Sulfinic acids; Esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0201939A 2002-06-20 2002-06-20 New combination SE0201939D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0201939A SE0201939D0 (sv) 2002-06-20 2002-06-20 New combination
ARP030102094A AR040202A1 (es) 2002-06-20 2003-06-11 Combinacion de un agente inhibidor de la secrecion de acido y un inhibidor de reflujo para el tratamiento de la gerd
AU2003239025A AU2003239025A1 (en) 2002-06-20 2003-06-16 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd
PCT/SE2003/001007 WO2004000855A1 (en) 2002-06-20 2003-06-16 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd
TW092116263A TW200400826A (en) 2002-06-20 2003-06-16 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of GERD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201939A SE0201939D0 (sv) 2002-06-20 2002-06-20 New combination

Publications (1)

Publication Number Publication Date
SE0201939D0 true SE0201939D0 (sv) 2002-06-20

Family

ID=20288297

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201939A SE0201939D0 (sv) 2002-06-20 2002-06-20 New combination

Country Status (5)

Country Link
AR (1) AR040202A1 (sv)
AU (1) AU2003239025A1 (sv)
SE (1) SE0201939D0 (sv)
TW (1) TW200400826A (sv)
WO (1) WO2004000855A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077345A1 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
WO2006050471A2 (en) * 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
WO2006071186A1 (en) * 2004-12-27 2006-07-06 Astrazeneca Ab Use of gabab receptor agonists
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
WO2009014490A1 (en) * 2007-07-25 2009-01-29 Astrazeneca Ab Combination of (3-amino-2-fluoropropyl)phosphinic acid and omeprazole for treating tlesr, gerd, and nerd

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9904507D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds

Also Published As

Publication number Publication date
TW200400826A (en) 2004-01-16
AU2003239025A1 (en) 2004-01-06
WO2004000855A1 (en) 2003-12-31
AR040202A1 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
SE0301888D0 (sv) New use VII
SE0301882D0 (sv) New use I
NO20045429L (no) Kombinasjon av organiske forbindelser
DE50310516D1 (de) Fredericamycin-derivate
ATE344029T1 (de) Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern
NO20072461L (no) Fremstilling og anvendelse av bifenyl-4-yl-karbonylaminosyre derivater for behandling av fedme
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
SE0201940D0 (sv) New combination II
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
WO2005044199A3 (en) Combination of proton pump inhibitor and sleep aid
DK1735296T3 (da) Materialer og fremgangsmåder til behandling af koagulationslidelser
TW200505829A (en) Protease inhibitors for coronaviruses and sars-cov and the use thereof
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
IS2575B (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
NO20076405L (no) Anvendelse av 24-nor-UDCA
SE0201939D0 (sv) New combination
DE50310038D1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
ME00549B (me) Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
SE0301883D0 (sv) New use II
DK1664044T3 (da) Monohydreret natriumsalt af S-tenatoprazol og dets anvendelse i form af en protonpumpehæmmer
NO20063790L (no) Substituerte azetidin sammensetninger som cyclooxygenase-1-cyclooxygenase-2-inhibitorer, og deres fremstilling og anvendelse som medikamenter
SE0002739D0 (sv) New use
SE0200198D0 (sv) New use